Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...
A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS)On-track to enable ...
19h
HealthDay on MSNFour Immunoassays for Neurofilament Light Chain Show Consistent Performance in ALSFour immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophi ...
Legendary "If Ever I See You Again" singer Roberta Flack has passed away at the age of 88 at her home in Manhattan surrounded ...
14h
Medpage Today on MSNNovel Agent Safe in ALS, Phase II Study SuggestsTetramethylpyrazine nitrone was safe for people with amyotrophic lateral sclerosis (ALS), but neither a high nor low daily ...
A measles outbreak in Canada's Ontario province continues to grow, with health officials reporting more than 140 cases on ...
THURSDAY, Feb. 27, 2025 (HealthDay News) -- A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and ...
Woolsey Pharmaceuticals today announced the successful completion of an extension to its Series B Preferred financing round ...
Following Pfizer’s acquisition, Biohaven’s valuation skyrocketed under Vlad Coric. Find out why BHVN stock’s growth potential ...
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / Rob Etherington, CEO, and Morgan Brown, CFO, of Clene Inc., will be presenting at this year's Investor Summit Virtual on March 11th. About Clene ...
Clene (NASDAQ: CLNN) announced that CEO Rob Etherington and CFO Morgan Brown will present at the Investor Summit Virtual on March 11, 2025. The even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results